Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024183
Filing Date
2024-10-01
Accepted
2024-10-01 16:15:07
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 form4-10012024_041004.html 4  
1 form4-10012024_041004.xml 4 3600
  Complete submission text file 0001415889-24-024183.txt   5189
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVENUE THERAPEUTICS, INC. 1140 AVENUE OF THE AMERICAS, FLOOR 9 NEW YORK NY 10036
Business Address
Jin David (Reporting) CIK: 0001930732 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 241343441